Product
AXL/PDGFRβ Therapeutic Aptamer (GL21.T/Gint4.T)
[CAT#: NV-2106-P88]
- Target:
- PDGFRB
- Product Type:
- Aptamers
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Product Overview
Description
Aptamer Role: Antagonist
SELEX Method: Cell-based SELEX
KD (nmol/L): 13/9.6
Composition: Conjugated with miR-137 and antimiR-10b
Therapeutic Application: Target glioma stem-like cells
SELEX Method: Cell-based SELEX
KD (nmol/L): 13/9.6
Composition: Conjugated with miR-137 and antimiR-10b
Therapeutic Application: Target glioma stem-like cells
Properties
Research Use Only
This product is for research use only.
Target Details
Target
PDGFRB
References
Esposito, C. L., Nuzzo, S., Kumar, S. A., Rienzo, A., Lawrence, C. L., Pallini, R., ... & De Franciscis, V. (2016). A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells. Journal of Controlled Release, 238, 43-57.
Publications
Publications (0)
Neural Antibodies
Cell Assay Reagents
For Research Use Only. Not For Clinical Use.
